Dr Adam John Bayes is a Psychiatrist & Senior Research Fellow, Black Dog Institute.
Dr Bayes is a clinician scientist with a special interest in mood disorders (depressive and bipolar conditions) including diagnosis, classification and treatment. He has a special interest in interventional psychiatry (e.g. rapidly acting antidepressants such as ketamine) and psychedelics.
Adam works at the interface of research and clinical application, and has an interest in developing models of care, previously leading the set-up of the BDI Ketamine Treatment Program which arose out of a clinical trial.
In addition to spending half of his time managing patients (with his greyhound co-therapist Willy), he is actively engaged in teaching and mentoring medical students, psychiatry registrars, higher degree researchers as well as contributing to treatment guidelines and conducting workshops for psychiatrists in the area of novel treatments.
0:00:00 Introduction
0:11:48 Catastrophic Treatment Resistant Depresson
0:19:32 Ketamine
0:27:40 Psychedelics
0:35:58 Psilocybin
0:38:26 Default Mode Network
0:57:56 MMicrodosing
1:01:14 Psychedelics research